1. Home
  2. RDHL vs BLMZ Comparison

RDHL vs BLMZ Comparison

Compare RDHL & BLMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • BLMZ
  • Stock Information
  • Founded
  • RDHL 2009
  • BLMZ 2017
  • Country
  • RDHL Israel
  • BLMZ Japan
  • Employees
  • RDHL N/A
  • BLMZ N/A
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • BLMZ
  • Sector
  • RDHL Health Care
  • BLMZ
  • Exchange
  • RDHL Nasdaq
  • BLMZ NYSE
  • Market Cap
  • RDHL 8.6M
  • BLMZ 8.7M
  • IPO Year
  • RDHL N/A
  • BLMZ 2024
  • Fundamental
  • Price
  • RDHL $6.99
  • BLMZ $0.49
  • Analyst Decision
  • RDHL
  • BLMZ
  • Analyst Count
  • RDHL 0
  • BLMZ 0
  • Target Price
  • RDHL N/A
  • BLMZ N/A
  • AVG Volume (30 Days)
  • RDHL 21.2K
  • BLMZ 155.2K
  • Earning Date
  • RDHL 12-27-2024
  • BLMZ 12-24-2024
  • Dividend Yield
  • RDHL N/A
  • BLMZ N/A
  • EPS Growth
  • RDHL N/A
  • BLMZ N/A
  • EPS
  • RDHL N/A
  • BLMZ N/A
  • Revenue
  • RDHL $3,707,000.00
  • BLMZ $1,246,643.00
  • Revenue This Year
  • RDHL $224.90
  • BLMZ N/A
  • Revenue Next Year
  • RDHL $82.69
  • BLMZ N/A
  • P/E Ratio
  • RDHL N/A
  • BLMZ N/A
  • Revenue Growth
  • RDHL N/A
  • BLMZ 29.63
  • 52 Week Low
  • RDHL $6.35
  • BLMZ $0.48
  • 52 Week High
  • RDHL $43.50
  • BLMZ $4.30
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 42.91
  • BLMZ N/A
  • Support Level
  • RDHL $7.09
  • BLMZ N/A
  • Resistance Level
  • RDHL $7.44
  • BLMZ N/A
  • Average True Range (ATR)
  • RDHL 0.53
  • BLMZ 0.00
  • MACD
  • RDHL -0.03
  • BLMZ 0.00
  • Stochastic Oscillator
  • RDHL 12.36
  • BLMZ 0.00

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.

About BLMZ BLOOMZ INC

BloomZ Inc operates as an audio-producing and voice actor managing company. The company provides audio production services and voice-acting educational services in Japan. The business lines of the company are the audio production business, the VTuber management business, and the voice actor workshop business. The audio production comprises producing audios for animations and video games using dubbing, BGM producing, and mixing techniques; the Vtuber management business creates motion-capture technology for streamers to provide the voice to stream real-time videos featuring human facial expressions and gestures; and the voice actor workshop provides practical voice acting services.

Share on Social Networks: